Epicutaneous Immunity and Onset of Allergic Diseases - Per-“Eczema”tous Sensitization Drives the Allergy March  by Matsumoto, Kenji & Saito, Hirohisa
Allergology International Vol 62, No3, 2013 www.jsaweb.jp 291
Review Series: Immune Responses in the Host-Environment Interface - Understanding
the Mechanisms of Allergic Sensitization
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ABSTRACT
Results from recent epidemiological studies strongly suggest that ingestion of food promotes immune tolerance
to food antigens, whereas exposure to food antigens through skin leads to allergic sensitization. A “dual-
allergen-exposure hypothesis” has been proposed to explain those findings. However, several other recent
studies have demonstrated that some allergic diseases can be successfully treated by recurrent epicutaneous
exposure to allergens. At a glance, these two sets of findings seem to be contradictory, but we think they pro-
vide important clues for understanding the mechanisms behind the allergy march.
Here, we propose that per-“eczema”tous sensitization drives the allergy march, and we introduce results
from several published studies in support of this hypothesis. We hope that this review may help in establish-
ment of new strategies for preventing the allergy march in the near future.
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INTRODUCTION
The allergy march is defined as the progression of al-
lergic diseases in infancy from food allergy and atopic
dermatitis to asthma and rhinoconjunctivitis.1 During
this march, both the offending allergens and the af-
fected organs change (Table 1). The exact underlying
mechanisms of why and how the antigens change
have not been fully elucidated, but an immune predis-
position towards Th2 is likely to play an important
role.
In this review, we propose a hypothesis that per-
“eczema”tous sensitization drives the allergy march,
and we introduce results from several published stud-
ies to support the validity of this hypothesis.
DUAL-ALLERGEN-EXPOSURE HYPOTHESIS
Oral Tolerance
All vertebrate animals with jaws eat plant andor ani-
mal proteins. The animals’ intestinal tract digests and
absorbs foreign proteins without inducing harmful
immune responses in the host. This is very important
and is called “oral tolerance.” In animal models, im-
mune responses―including specific IgE antibody
production―to intravenously or intraperitoneally ad-
ministered or transplanted antigens were almost com-
pletely prevented when the antigens were orally ad-
ministered beforehand.2 Subsequent studies indi-
cated that intestinal microbiota,3 especially indige-
nous Clostridium species,4 are critical for induction of
oral tolerance in animal models.
In 2008, Du Toit et al. demonstrated that Jewish
children in the UK have an almost 10-fold higher
prevalence of peanut allergy compared with Jewish
children in Israel, and they found that Israeli infants
are fed peanut products in large quantities in the first
year of life, whereas UK infants do not.5 This observa-
tion clearly demonstrates that induction of oral toler-
ance via early intake seems to inhibit subsequent de-
velopment of food allergy. In a similar context, mater-
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Table　1　Allergens and affected organs in the allergy march
Disease Major allergens Affected organs
Food allergy Food Skin, Intestine, Mucosa
Atopic dermatitis Staphylococcus aureus Skin
Food, Airborne-antigens
Fungal protein MGL_1304†
Asthma House dust mite, fungi Lung
Rhinoconjunctivitis Pollen, fungi Nose, eyes
†An antigen from Malassezia globosa was recently identifi ed in perspiration (J Allergy Clin Immunol. DOI: 10.1016/j.jaci.2013.03.047).
nal dietary antigen avoidance during pregnancy or
lactation with the goal of preventing atopic diseases
in the child is no longer recommended.6,7
Epicutaneous Sensitization?
In 2003, Lack et al. analyzed prospective cohort data
from more than 1,300 preschool children in the UK
and demonstrated that a convincing history of peanut
allergy was significantly associated with the use of
skin preparations containing peanut oil (odds ratio,
6.8; 95% confidence interval, 1.4 to 32.9).8 A subse-
quent study reported that peanut protein was unde-
tectable in skin preparations containing peanut oil,9
but the environmental presence of peanut allergen,
such as on tabletops or on hands after applying pea-
nut butter, even after washing with water alone (no
soap), could represent another source of topical expo-
sure.10 Add in the facts that biologically active peanut
protein in household dust is related to household pea-
nut consumption11 and that household peanut con-
sumption is a risk factor for development of peanut al-
lergy12 and it seems clear that epicutaneous exposure
to food antigens is a risk factor for food allergy, pre-
sumably through epicutaneous sensitization.
In 2008, Lack postulated a new “dual-allergen-
exposure hypothesis” that ingestion of food promotes
immune tolerance to food antigens, whereas expo-
sure to food antigens through skin facilitates allergic
sensitization.13 Several lines of evidence support that
hypothesis, including that loss-of-function variants in
the filaggrin gene (FLG) are a significant risk factor
for peanut allergy.14 Filaggrin is expressed only in
the skin, not in the intestinal wall or bronchi, suggest-
ing that impaired barrier function of the skin but not
of the intestine may facilitate epicutaneous antigen
uptake and lead to allergic sensitization.
Recently in Japan, nearly 2,000 newly-diagnosed
wheat-allergy adults were reported to have become
sensitized by using a special facial soap containing
hydrolyzed wheat protein.15 This also points to the
importance of epicutaneous exposure in development
of food allergy. Of note, these patients had shown no
symptoms upon ingestion of wheat products before
use of the soap, suggesting that epicutaneous sensiti-
zation can occur even in individuals with established
oral tolerance. In a mouse model, recurrent epicuta-
neous peanut exposure induced IgE-synthesis, and it
prevented induction of oral tolerance to peanuts and
even partially abrogated existing tolerance to pea-
nuts.16
EPICUTANEOUS TOLERANCE?
In 2009, Senti et al. reported treating seasonal pollen
allergy patients in a monocentric, placebo-controlled,
double-blind trial by epicutaneous administration of
vaseline patches containing grass pollen allergen.17
Treatment took place before and during the pollen
season, and allergen-treated patients showed signifi-
cantly decreased scores in nasal provocation tests
and clinical symptoms during the pollen season. By
2012, eight studies had successfully used similar
epicutaneous antigen exposure methods in patients
with pollen allergies and patients with food aller-
gies.18 A number of animal studies have followed up
the efficacy.19,20
High molecular weight proteins had been thought
to be unabsorbable via the skin. However, a recent
study demonstrated that although they cannot be ab-
sorbed through intact skin, but they can be taken up
by dendritic cells,19 especially through hair follicles.21
In addition, the major T cell phenotype emigrating
from the skin during a cutaneous immune response
in mice was reported to be activated regulatory T
cells with high expression of Foxp3, a T-cell master
gene having a regulatory property.22,23 This observa-
tion strongly suggests that the skin is a tolerogenic
organ.
DO EPICUTANEOUSLY ADMINISTERED ANTI-
GENS INDUCE ALLERGIC SENSITIZATION, OR
TOLERANCE?
A carefully conducted animal study provided intrigu-
ing information that intact skin, not stripped skin, is
crucial for the safety and efficacy of peanut epicutane-
ous immunotherapy.24 In fact, prospective cohort
studies demonstrated eczema to be a risk factor for
hen’s egg allergy25 and peanut allergy.8,26 Sensitiza-
tion to latex was also strongly associated with the
presence of hand eczema.27
These clinical and experimental observations
strongly indicate that exposure of eczematous skin,
but not intact skin, to food proteins is a true risk fac-
Sensitization via Eczema & Allergy March
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Table　2　Proposed factors associated with per-eczematous 
sensitization
Skin Barrier Damage
Scratching
Protease antigens
Increase in pH of the skin
Alarmin/DAMPs (damage-associated molecular patterns)
Eosinophil-derived neurotoxin (EDN)
IL-33
Histamine
Microbe-associated Adjuvant
Staphylococcal superantigens
Cytokines Produced by Keratinocytes
Thymic stromal lymphopoietin (TSLP)
Phenotype of Antigen-presenting Cells
IgE-bearing Langerhans cell (LC)
tor for sensitization to food antigens.
ECZEMA IS A STRONG RISK FACTOR FOR SUB-
SEQUENT DEVELOPMENT OF ALLERGIC DIS-
EASES
Infants often suffer from various types of dermatitis.
In an earlier prospective cohort study, we looked for
associations between various types of dermatitis in in-
fancy and subsequent development of allergic symp-
toms.28 Analyses of infants with four types of dermati-
tis (infantile eczema, seborrheic dermatitis, intertrigo
and diaper dermatitis) that manifested independently
in the first month of life showed that neonates with in-
fantile eczema were diagnosed with atopic dermatitis
significantly earlier and had a significantly higher
prevalence of wheezing than infants without infantile
eczema until 2 years of age. In addition, a recent
large-scale cohort study concluded that eczema in in-
fancy might have a causal effect on hay fever in chil-
dren with, and perhaps without, asthma.29
It has also been clearly demonstrated that atopic
dermatitis at age 2 or 3 can predict subsequent devel-
opment of asthma both in the general population30
and in wheezing children.31 This is the typical natural
course of allergic diseases in young children (allergy
march).1
WHY DOES PER-“ECZEMA”TOUS SENSITIZA-
TION SKEW IMMUNE RESPONSES TOWARDS
TH2?
In eczematous lesions, the skin barrier function is
usually impaired. However, an animal model with
simple barrier dysfunction, such as filaggrin (flg)-
mutation (ftft mice), exhibited a Th17-skewing but
not Th2-skewing sensitization pattern.32 This sug-
gests involvement of some other factor(s) in allergic
sensitization that occurs when eczematous skin is ex-
posed to antigens. Table 2 summarizes the factors
proposed as promoting Th2-immune responses in ec-
zematous lesions.
Skin Barrier Damage
Mechanical skin injury (tape stripping) induced a
Th2 immune response in the draining lymph nodes in
a damage-dependent manner,33 at least in part by in-
ducing cutaneous thymic stromal lymphopoietin
(TSLP) expression.34 Scratching skin may cause epi-
thelial cell and endothelial cell damage and allow re-
lease of damage-associated molecular patterns
(DAMPs); this will be discussed later.
Protease Antigens
A major airborne antigen, house dust mite, is known
to have protease activity.35,36 Topical application of
such proteases not only reduces barrier function of
the skin, which increases permeability,37 but also acti-
vates protease-activated receptor 2, which delays epi-
dermal barrier recovery.38 In addition, protease activ-
ity in the skin causes IL-33ST2-dependent immune
responses39 and enhances TSLP production.40
Increase in pH
An increase in skin pH has been demonstrated in pa-
tients with eczema41 or FLG-loss-of-function muta-
tions.42 An increased pH in the stratum corneum
leads to degradation of lipid-processing enzymes
(necessary for production of natural moisturizing fac-
tor from filaggrin molecules)43 and facilitates Staphy-
lococcus aureus (S. aureus) growth.44
AlarminDAMPs
One of the biggest advances in immunology in recent
decades is the discovery that immune systems are ac-
tivated by recognition of damaged cells.45 The spe-
cific molecular patterns triggering this are called
“alarmins” or DAMPs.46
Eosinophil-derived neurotoxin, one of the major
granular proteins in eosinophils, can act as an alarmin
to activate dendritic cells and trigger Th2 immune re-
sponses.47 In our aforementioned cohort study, we
found significant eosinophilia in the cord blood of
neonates who developed infantile eczema compared
with those without infantile eczema, suggesting in-
volvement of eosinophils in subsequent development
of atopic dermatitis or wheeze.28
IL-33, a member of the IL-1 family, is constitutively
expressed in the nucleus of endothelial cells and epi-
thelial cells in vivo48 and is released upon cellular
damage, but not during apoptosis.49 Keratinocyte
lysate contains biologically active IL-33 protein.50
This novel cytokine reportedly activates a number of
different cell types, including mast cells, tissue resid-
ual cells and type 2 innate lymphoid cells (ILC2), and
it probably plays critical roles in the development of
allergic diseases.51
Staphylococcus-Derived Superantigens
S. aureus infection is one of the most frequent causes
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of acute exacerbation of atopic dermatitis, and im-
paired local bactericidal activity has been reported in
atopic skin.52 Staphylococcus-derived superantigens
are known to directly cause dermatitis of the skin53
and induce IgE synthesis.54 Notably, superantigen-
induced immune reactions are only partially inhibited
by corticosteroids.55
Phenotype of Antigen-Presenting Cells
Langerhans cells, which are skin-dwelling, profes-
sional antigen-presenting cells, are known to play
critical roles in the induction of atopic dermatitis-like
inflammation56 as well as antigen-specific IgE synthe-
sis.57 A recent study demonstrated that signaling
through TSLP is indispensable for this dermatitis-like
inflammation56 and Th2 polarization.58
Langerhans cells express high-affinity IgE recep-
tors (FcεRI), especially in atopic individuals.59 In a
mouse model, FcεRI engagement of Langerhans cell-
like dendritic cells induced accumulation of Th2 cells
in the skin, whereas another IgG-bearing type of den-
dritic cell, the so-called “inflammatory dendritic epi-
dermal cell (IDEC)”, caused Th1 cell accumulation.60
CONCLUSIONS
In this review we proposed that per-“eczema”tous
sensitization drives the allergy march, and we pre-
sented evidence in support of this hypothesis. We
strongly hope that authors of earlier clinical studies
will revisit their data and patients and look for possi-
ble involvement of eczema in the development of food
allergy and other allergic diseases, as well as for pos-
sible effects of FLG-mutations or environmental food
antigen exposure.
We also hope that clinical trials will investigate in-
tervention in infantile eczema with the goal of pre-
venting allergic sensitization, especially to food anti-
gens. It is our fervent hope that this review will facili-
tate early development of novel strategies for prevent-
ing the allergic march.
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